Defining the Optimal Cryoballoon Duration Therapy for Treatment of Atrial Fibrillation: Defining the Optimal Cryoballoon Duration Therapy for Treatment of Atrial Fibrillation: The 1-2-3 Study
Clinical trial NCT02074566 · COMPLETED
Trial details
- NCT number
- NCT02074566
- Sponsor
- Harald Verheij
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-14
- Primary completion
- 2018-03-08
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.